Siena, Italy

Jlenia Brunetti

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Setlance S.r.l.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jlenia Brunetti: Innovator in Biological Fluid Treatment

Introduction

Jlenia Brunetti is a notable inventor based in Siena, Italy. She has made significant contributions to the field of biotechnology, particularly in methods for removing bacterial toxins from biological fluids. Her innovative approach has the potential to impact various medical applications.

Latest Patents

Jlenia holds a patent for "Methods for removing bacterial toxins from a biological fluid." This patent focuses on the removal of bacterial toxins such as lipopolysaccharide and lipoteichoic acid using specific peptides. The peptides, selected from KKIRVRLSA (SEQ ID NO:1), RRIRVRLSA (SEQ ID NO:2), KRIRVRLSA (SEQ ID NO:3), and RKIRVRLSA (SEQ ID NO:4), are covalently attached to a solid support through the C-terminus, optionally with the interposition of a linker. This innovative method showcases her expertise in addressing critical challenges in medical treatments.

Career Highlights

Jlenia is associated with Setlance S.r.l., where she continues to develop her research and innovations. Her work is characterized by a commitment to advancing the understanding and treatment of bacterial infections, which is crucial in the medical field.

Collaborations

Jlenia collaborates with talented individuals such as Alessandro Pini and Chiara Falciani. These partnerships enhance her research efforts and contribute to the development of effective solutions in biotechnology.

Conclusion

Jlenia Brunetti is a pioneering inventor whose work in removing bacterial toxins from biological fluids represents a significant advancement in biotechnology. Her contributions are vital for future medical applications and demonstrate the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…